A detailed history of Ruffer LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ruffer LLP holds 75,501 shares of HRMY stock, worth $2.47 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
75,501
Holding current value
$2.47 Million
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$31.86 - $41.49 $2.41 Million - $3.13 Million
75,501 New
75,501 $2.6 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Ruffer LLP Portfolio

Follow Ruffer LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.